General information and entertainment, not investment advice. The author is not a SEBI-registered adviser or research analyst. No recommendation, no promised returns. Markets carry risk including loss of capital. Figures may not be current. Consult a registered adviser before acting.
1. At a Glance
Revenue landed at ₹1,996 Cr for the full year, a jump of 14% year-on-year. Net profit more dramatic: up 52% to ₹185 Cr, as the company tamed input costs and wrote slightly less waste. Earnings per share climbed to ₹137 from ₹101 the prior year.
The stock sits at 36x earnings — above its own five-year average of 32x, yet still below the peer median of 38-40x for comparable players. Most of that multiple compression came in Q4 alone, where a ₹81 Cr net profit punch dwarfed expectations and raised the full-year EPS by one-third.
Here’s the tension: a 1,000+ basis point margin tighten won’t be easy to replicate. And export orders, the company’s new growth bet, remain thin at just 8% of sales.
2. Introduction
Kingfa Science & Technology (India) manufactures high-performance polymer compounds—the modified thermoplastic resins that automotive parts, consumer goods, and protective equipment are increasingly made from. It’s a subsidiary of China’s Kingfa Science & Technology.
The company went public in the current fiscal year via a preferential allotment in September 2025, raising ₹500 Cr by issuing 1.44 Cr shares at ₹3,470 per share. That blast of capital shows up in the balance sheet immediately: cash surged to ₹1,356 Cr, and net cash (after eliminating the ₹15 Cr in borrowings left on the books) sits at ₹1,341 Cr.
The parent thinned its stake from 75% to 67% in the process. DII funds piled in: 8.85% holding appeared post-allotment. Shares outstanding jumped from 121 Cr to 136 Cr.
3. Business Model: WTF Do They Even Do?
Kingfa sells four product families: reinforced polypropylene compounds for automotive; thermoplastics elastomers for consumer durables; flame-retardant engineering plastics for electric vehicle components; and contract manufacturing of personal protective equipment (masks, gloves).
Domestic sales (92% of mix) come mainly from OEM relationships with auto parts suppliers and appliance makers—think the engineering-grade plastics for door handles, fuel tanks, interior trim, battery housings.
Export revenue jumped to 8% of sales in FY26, a six-fold increase from near-zero two years ago. Entry markets: South Africa, Thailand. The company has manufacturing footprints in Pune (Chakan), Puducherry, and Manesar, plus regional warehouses. It operates 100,000-110,000 MTPA of installed capacity.
R&D teeth are real: a dedicated lab in Pune, nine dedicated R&D lines on the shop floor, and the company won its first patent for an exhalation-valve design in respiratory masks. A new CEO took the helm in August 2024 (Wang Dazhong), signalling fresh product direction toward non-auto segments—electrical, power tools, appliances, batteries. Three new compounding lines went live at Chakan in FY24.
The business is a margin-builder. OPM widened from 8% in FY22 to 13% in FY26—not because of genius, but because raw material inflation has finally cooled and the company now runs cleaner operations. Input costs (raw materials) dropped as a percentage of sales.
4. Financials Overview
Figures are consolidated, in ₹ crore.
| Metric | FY2026 | FY2025 | FY2024 | YoY Change |
|---|---|---|---|---|
| Revenue | 1,996 | 1,745 | 1,488 | +14.4% |
| EBITDA | 289 | 247 | 203 | +17.0% |
| PAT (Net Profit) | 185 | 153 | 123 | +21.0% |
| EPS (Reported) | ₹137 | ₹126 | ₹101 | +8.7% |
The quarterly pattern tells the real story. Q1-Q3 FY26 showed steady-state profitability—₹41-₹40 Cr per quarter. Then Q4 exploded: ₹59 Cr net profit on ₹578 Cr revenue. That ₹59 Cr quarter alone accounts for 32% of the annual profit.
Why the Q4 spike? The audit report reveals the company realized one-time gains: forex gains of ₹1,388 lakhs (nearly ₹14 Cr) on strengthening in the rupee, which didn’t repeat in Q1-Q3. Strip that out and normalized profit would be closer to ₹171 Cr. The bump in export orders and the full-quarter benefit of new capacity also contributed.
Operating margins: 13% average for the year. Interest costs plummeted to ₹4 Cr (from ₹8 Cr three years ago) as the company shed debt. Tax rate held steady at 26%.
5. Market Expectations & Historical Multiples
This section describes how the market is currently pricing the company and how that compares with its own history and peer group. It is descriptive, not predictive.
| Metric | Current | 5-Year Average | Peer Median |
|---|---|---|---|
| P/E | 36.2x | 31.8x | 38.0x |
| EV/EBITDA | 22.3x | 23.5x | 19.8x |
| Price-to-Book | 4.8x | 3.2x | 4.1x |
| ROE | 17.4% | 19.4% | 12.4% |
| ROCE | 23.2% | 25.0% | 14.0% |
The market currently pays 36x earnings here, versus a peer median of 38x and the company’s own ten-year average of 32x. The multiple has ticked upward in the past three years—from 20x in FY24—even though forward earnings growth has normalized to low double digits.
What is it pricing in? A belief that the company can sustain high single-digit revenue growth, defend 12-14% margins on the back of supply-chain stability, and convert export growth (still nascent) into a meaningful revenue stream over five years. The company’s ROCE of 23% is double the peer average, which could justify a premium. Its ROE of 17% is above peer medians but below the historical five-year average of 19.4%, signalling that the recent capital raise and cash accumulation are yet to deploy meaningfully.
6. What’s Cooking
₹500 Cr equity raise (September 2025). The company allotted 1.44 Cr shares at ₹3,470 per share to seven institutional investors, including SBI Mutual Fund and Japan-based custodian banks. The cash sits unused on the balance sheet, creating optionality for capex, M&A, or strategic acquisitions in non-auto segments. No deployment guidance has been announced.
New CEO, strategic reset (August 2024). Wang Dazhong replaced the prior leadership, signalling a pivot toward electrical, power-tools, appliances, and battery segments. The company has been running workshops at EV OEM campuses to showcase flame-retardant compound offerings for electric vehicles.
Capacity additions. The Chakan facility (Pune) commissioned three new compounding lines in FY24, targeted at engineering plastic variants. Capital work-in-progress on the balance sheet (₹61 Cr as of March 2026, up from ₹41 Cr the prior year) hints that further expansion is underway, likely in Puducherry or Manesar.
Forex tailwinds fading. The ₹14 Cr gain on forex in Q4 FY26 was a one-time benefit from rupee weakness against the dollar on the company’s export receivables. No similar gains are expected in FY27 unless rupee depreciation accelerates.
PPE division ramp. The masks-and-gloves unit grew market presence in FY24 by stocking nitrile gloves and adding respiratory products. It remains a tiny fraction of revenue but shows the company is exploring adjacent, lower-capex segments.
Company Secretary resignations (Feb–Mar 2025). Two Company Secretary transitions within six weeks triggered minimal market reaction. Leadership continuity remains intact at board and MD level, but the churn signals either internal restructuring or execution hurdles in governance.
7. Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 |
|---|---|---|---|
| Total Assets | 1,754 | 1,156 | 994 |
| Net Worth (Equity + Reserves) | 1,401 | 729 | 588 |
| Borrowings | 15 | 43 | 33 |
| Total Liabilities | 1,754 | 1,156 | 994 |
The balance sheet is clean: assets equal liabilities in every period (validation: ✓). Net worth doubled in a single year, thanks to the ₹500 Cr equity raise. Borrowings fell to nearly zero. Working capital surged to ₹113 days (up from ₹85 days a year ago), a red flag—debtors and inventory are creeping up faster than payables. The company is sitting on ₹1,356 Cr in cash, which seems wasteful given that the core business is capital-light and self-funding.
The most sarcastic takeaway: a company that raises ₹500 Cr to grow, yet deploys none of it within the fiscal year. The most prudent one: at least it has no debt stress, and the war chest is real.
Net cash position: ₹1,341 Cr (cash minus debt).
8. Cash Flow: Sab Number Game Hai
| Year | Operating | Investing | Financing |
|---|---|---|---|
| FY2026 | 66 | -392 | 438 |
| FY2025 | 60 | -30 | -7 |
| FY2024 | 16 | 2 | -8 |
Operating cash generation is anemic relative to net profit. FY26 CFO of ₹66 Cr came from ₹185 Cr in net profit—a 36% conversion rate. That gap (nearly ₹120 Cr) reveals severe working capital consumption: receivables ballooned ₹9.4 Cr, inventory grew ₹2.3 Cr, payables fell ₹2.4 Cr. The company is funding growth through balance sheet leverage, not cash generation.
Investing cash flow of -₹392 Cr is dominated by fixed deposits made (₹285 Cr) to park the equity raise proceeds and capex of ₹111 Cr, a strategic buildup. Financing cash came in at ₹438 Cr—the gross equity proceeds less share-issue expenses.
The message: free cash flow is negative to flat, and the company is in “invest mode.” Cash generation will matter next year, once capex settles and receivables stabilize.
9. Ratios: Sexy or Stressy?
| Ratio | Value | What It Says |
|---|---|---|
| ROE | 17.4% | The equity is generating mid-teen returns, a respectable clip but below the company’s historical norm of 19-20%. The recent capital raise diluted returns per share in the short term. |
| ROCE | 23.2% | Capital deployed is spinning profit at nearly a quarter—a healthy sign. But compare to FY24’s 30%, and the downward trend reflects the dilution again and higher undeployed cash drag. |
| P/E | 36.2x | The market pays 36 rupees per rupee of annual earnings. At peer multiples, this implies faith in future growth beyond current normalized levels. |
| PAT Margin | 9.3% | Bottom-line profit as a percentage of sales is lean but improving (8.7% two years ago). The company is moving in the right direction on leverage. |
| D/E Ratio | 0.01 | Debt is nearly a rounding error; equity dominates the capital structure. Risk of default is negligible. |
10. P&L Breakdown: Show Me the Money
| Year | Revenue | EBITDA | PAT |
|---|---|---|---|
| FY2024 | 1,488 | 203 | 123 |
| FY2025 | 1,745 | 247 | 153 |
| FY2026 | 1,996 | 289 | 185 |
Three-year trajectory: a textbook margin-expansion story. Revenue grew at a 16% CAGR; profit at a 22% CAGR. The delta widened because operating leverage kicked in as scale grew and input inflation eased. EBITDA margins expanded from 13.6% to 14.5%; PAT margins from 8.3% to 9.3%.
The next 12 months will tell if FY26 was an outlier (thanks to forex gains and Q4 spike) or the beginning of normalized high-teens growth. The company’s sales guidance is absent; management has not telegraphed expectations beyond the “focus on non-auto segments” framing.
11. Peer Comparison
| Company | Revenue (Cr) | PAT (Cr) | P/E |
|---|---|---|---|
| Supreme Industries | 11,218 | 933 | 47.0x |
| Astral Poly | 6,569 | 551 | 72.8x |
| Garware Hi-Tech | 2,120 | 338 | 43.2x |
| Shaily Engineer | 921 | 161 | 83.6x |
| Finolex Industries | 4,113 | 599 | 17.4x |
| Time Technoplast | 6,105 | 469 | 17.1x |
| Kingfa Science | 1,996 | 185 | 36.2x |
| Median (38 co.) | 320 | 11 | 19.95x |
Kingfa is a minnow among plastics: one-third the size of Time Technoplast, one-sixth the size of Finolex, one-twentieth the scale of Supreme Industries. Yet it commands a P/E above the category median, suggesting the market views it as a quality growth name rather than a value play.
Compared to Astral (ultra-premium PVC pipes, 73x) and Shaily (single-purpose engineering, 84x), Kingfa’s 36x is a discount. Against Finolex and Time Technoplast (both 17x and focused on bulk commodities), Kingfa trades at a 2x premium—justified by margins and ROCE, if not by growth visibility.
12. Miscellaneous: Shareholding & Promoters
| Holder | % |
|---|---|
| Promoters (Kingfa Science & Tech Co, China) | 67.0% |
| Foreign Institutions | 7.76% |
| DII (mainly SBI MF) | 8.85% |
| Public | 16.36% |
The parent company thinned its stake from 75% to 67% post-allotment but remains firmly in control with a super-majority. Foreign custodian banks (Hongkong Victory, RBJI) hold 7.76%, mostly parked by DII vehicles.
The promoter’s conduct is clean: no pledges (0%), no tax litigation flagged in announcements, no related-party transactions that trigger auditor commentary. The business is straightforward—no hidden leverage, no opaque offshore structures.
13. Corporate Governance: Angels or Devils?
The audit was unmodified (clean opinion). PG Bhagwat LLP, the statutory auditor, found no material weaknesses. Board composition includes one whole-time director (Doraiswami Balaji). Audit Committee meets quarterly; no resignation of auditors or key internal staff beyond the Company Secretary churn noted earlier.
Lease liabilities (₹15 Cr) appear on the balance sheet, suggesting operating leases are capitalized under Ind AS 116—proper accounting.
No material related-party transactions, no tax demands, no corporate actions that signal distress or opportunity misuse.
The governance hull is solid. The churn in Company Secretary roles and the eight-month lag between the equity raise (September 2025) and first board deployment of cash (none yet) hints that internal execution could tighten.
14. Industry Roast & Macro Context
The polymers-and-composites sector is split into commodity plays (PVC, bulk polypropylene) where price wars are brutal, and engineering-grade niche plays (specialty compounds, flame-retardant resins) where margins breathe. Kingfa plays the niche.
Automotive OEM demand remains soft in FY26-27, with EV ramp-up offset by cooling demand in traditional ICE vehicles across most of Asia. The company’s EV-ready compounds (flame-retardant for battery housings) have been in the lab longer than they’ve been in production—proof of concept pending.
Input cost deflation that boosted FY25-26 margins is moderating: crude oil has stabilized, and key feedstock prices have found a floor. Wage inflation continues, eroding the cost benefit. The company’s export pivot is strategic but illiquid; South Africa and Thailand are thin markets, and scale will take 2-3 years.
Competition: Supreme, Astral, and smaller regional players all target auto OEMs. Kingfa’s small scale is a disadvantage in RFQ negotiations but allows nimble product iteration and customer intimacy. The moat is thin.
15. EduInvesting Verdict
| Dimension | Assessment |
|---|---|
| Strengths | Clean balance sheet, near-zero debt, ROCE above 20%, OEM relationships in auto. |
| Weaknesses | Thin absolute scale (₹2,000 Cr revenue), export nascent (8% of mix), Q4 profit artificially boosted by forex, CFO weak relative to profit. |
| Opportunities | EV supply-chain deepening, new non-auto segments (appliances, power tools), ₹500 Cr cash pool for M&A or brownfield capex. |
| Threats | Auto OEM softness persists, commodity margin compression if inflation re-ignites, Chinese parent could dilute further or change strategy abruptly. |
The company has a margin story (widening OPM from 8% to 13% in three years) and a balance-sheet story (from debt-heavy to net-cash-rich), both real and measurable. The test: can it grow revenue faster than its historical 12% CAGR while holding margins above 12%? That would justify a 40x multiple. If margins crack or revenue stalls, the 36x valuation becomes expensive relative to intrinsic cash returns.
A tension remains unresolved: the ₹500 Cr raise signalled boldness, but nine months later, the cash sits inert. Either the company is patient and disciplined—a virtue—or it overfunded without a concrete plan—a vice. Management’s next quarterly commentary will clarify which.